A self-management program for Chinese cancer survivors
Official title: How to Prevent Lost in Transition? - Adaptive Randomised Controlled Trial of a Self-management Based Survivorship Intervention for Chinese Cancer Survivors
Run by The University of Hong Kong · NCT05534386 · Data updated 2026-11-12
This study is testing a self-management program to help Chinese cancer survivors feel better, manage their weight, and improve their overall quality of life after finishing treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 486 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 7 sites (Hong Kong and 6 other locations) |
| Status | Recruiting |
| Started | April 12, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2027 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT05534386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Cantonese- or Mandarin-speaking Chinese patients who have completed curative cancer treatment within the past six months.
✕Probably not a fit
Patients diagnosed with metastatic cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a cancer survivorship care intervention aimed at reducing physical symptom distress and improving weight management, self-efficacy, and health-related quality of life among Chinese patients who have recently completed curative cancer treatment. Utilizing a sequential multiple assessment randomized controlled trial (SMART) approach, the intervention includes a multidisciplinary team assessment and personalized advice on symptom management and lifestyle modifications. Participants will be compared against those receiving standard pamphlets for symptom management to determine the effectiveness of the intervention. Additionally, a step-up targeted personalized intervention will be tested for patients who continue to experience distress or weight management issues.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and self-management skills of cancer survivors.
How similar studies have gone: Other studies have shown success with similar survivorship interventions, indicating potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cantonese- or Mandarin-speaking Chinese patients diagnosed curable cancer * have completed primary and adjuvant treatment within the past six months Exclusion Criteria: * Patients diagnosed with metastatic cancer
Where it's running
-
Queen Mary Hospital-Department of Obstetrics & Gynaecology
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital-Department of Oncology
Hong Kong, Hong Kong Recruiting -
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong Recruiting -
Kwong Wah Hospital-Breast Center
Hong Kong, Hong Kong Active not recruiting -
Pamela Youde Nethersole Eastern Hospital-Department of oncology
Hong Kong, Hong Kong Active not recruiting -
Prince of Wales Hospital-Department of Surgery
Hong Kong, Hong Kong Active not recruiting
Show 1 more location
-
Tung Wah Hospital-Department of Surgery
Hong Kong, Hong Kong Active not recruiting
Study contacts
- Principal investigator: Wendy Wing Tak Lam, PhD — School of Public Health, The University of Hong Kong
- Study coordinator: Wendy Wing Tak Lam, PhD
- Email: wwtlam@hku.hk
- Phone: +852 39179878
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients
The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.
-
Family-based weight wellness with medically tailored groceries and group visits
We’re testing a family-focused program that uses group medical visits and medically tailored groceries to help kids 12–17 with overweight or obesity, along with their parents.
-
Elecoglipron for weight management in adults with obesity or overweight with or without type 2 diabetes
This study tests whether taking elecoglipron once daily helps adults with obesity or overweight, with or without type 2 diabetes, lose more weight than placebo when combined with diet and exercise.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.